Treffer 1 - 8 von 8 für Suche 'Ottenbourgs, Tine', Suchdauer: 0,43s Treffer weiter einschränken
  1. 1
    Changes in leukoencephalopathy and serum neurofilament after (neo)adjuvant chemotherapy for breast cancer

    Changes in leukoencephalopathy and serum neurofilament after (neo)adjuvant chemotherapy for breast cancer von Schroyen, Gwen, Sleurs, Charlotte, Ottenbourgs, Tine, Leenaerts, Nicolas, Nevelsteen, Ines, Melis, Michelle, Smeets, Ann, Deprez, Sabine, Sunaert, Stefan

    Veröffentlicht in Translational oncology

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  2. 2
    Novel Endocrine Therapeutic Opportunities for Estrogen Receptor-Positive Ovarian Cancer-What Can We Learn from Breast Cancer?

    Novel Endocrine Therapeutic Opportunities for Estrogen Receptor-Positive Ovarian Cancer-What Can We Learn from Breast Cancer? von Ottenbourgs, Tine, Van Nieuwenhuysen, Els

    Veröffentlicht in CANCERS

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  3. 3
    Novel Endocrine Therapeutic Opportunities for Estrogen Receptor-Positive Ovarian Cancer-What Can We Learn from Breast Cancer?

    Novel Endocrine Therapeutic Opportunities for Estrogen Receptor-Positive Ovarian Cancer-What Can We Learn from Breast Cancer? von Ottenbourgs, Tine, Van Nieuwenhuysen, Els

    Veröffentlicht in Cancers

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  4. 4
    A phase II, multicenter, open-label study of abemaciclib and letrozole in patients with estrogen receptor-positive rare ovarian cancer: ALEPRO trial

    A phase II, multicenter, open-label study of abemaciclib and letrozole in patients with estrogen receptor-positive rare ovarian cancer: ALEPRO trial von Ottenbourgs, Tine, van Gorp, Toon, Kridelka, Frederic, Baert, Thais, Denys, Hannelore, Selle, Frederic, Baas, Inge, Van Rompuy, Anne-Sophie, Lambrechts, Diether, Van Nieuwenhuysen, Els


    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  5. 5
    A phase II, multicenter, open-label study of abemaciclib and letrozole in patients with estrogen receptor-positive rare ovarian cancer: ALEPRO trial

    A phase II, multicenter, open-label study of abemaciclib and letrozole in patients with estrogen receptor-positive rare ovarian cancer: ALEPRO trial von Ottenbourgs, Tine, van Gorp, Toon, Kridelka, Frédéric, Baert, Thaïs, Denys, Hannelore, Selle, Frédéric, Baas, Inge, Van Rompuy, Anne Sophie, Lambrechts, Diether, Van Nieuwenhuysen, Els


    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  6. 6
    A phase II, multicenter, open-label study of abemaciclib and letrozole in patients with estrogen receptor-positive rare ovarian cancer : ALEPRO trial

    A phase II, multicenter, open-label study of abemaciclib and letrozole in patients with estrogen receptor-positive rare ovarian cancer : ALEPRO trial von Ottenbourgs, Tine, van Gorp, Toon, Kridelka, Frédéric, Baert, Thaïs, Denys, Hannelore, Selle, Frédéric, Baas, Inge, Van Rompuy, Anne-Sophie, Lambrechts, Diether, Van Nieuwenhuysen, Els


    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  7. 7
    Changes in leukoencephalopathy and serum neurofilament after (neo) adjuvant chemotherapy for breast cancer

    Changes in leukoencephalopathy and serum neurofilament after (neo) adjuvant chemotherapy for breast cancer von Schroyen, Gwen, Sleurs, Charlotte, Ottenbourgs, Tine, Leenaerts, Nicolas, Nevelsteen, Ines, Melis, Michelle, Smeets, Ann, Deprez, Sabine, Sunaert, Stefan

    Veröffentlicht in TRANSLATIONAL ONCOLOGY

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  8. 8
    Alterations in the MAPK pathway: promising biomarkers for MEK1/2 inhibition

    Alterations in the MAPK pathway: promising biomarkers for MEK1/2 inhibition von Baert, Thais, Ottenbourgs, Tine, Van Gorp, Toon, Van Nieuwenhuysen, Els

    Veröffentlicht in GYNECOLOGY AND PELVIC MEDICINE
    Volltext bestellen
    Artikel

    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: